Skip to content

Effect of Electroacupuncture on survival with a favorable neurological outcome of Post-cardiac Arrest Syndrome: a pilot randomized controlled trial

Effect of Electroacupuncture on survival with a favorable neurological outcome of Post-cardiac Arrest Syndrome: a pilot randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040040
Enrollment
Unknown
Registered
2020-11-19
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest

Interventions

Sponsors

Department of Emergency Medicine of Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Cardiac arrest is caused by respiratory failure or hypovolemic shock; 2. In-Hospital Cardiac Arrest; 3. Aged 18-85 years old; 4. Patients with return of spontaneous circulation (ROSC) that is sustained for >=20 minutes; 5. Glasgow coma score <=8 after ROSC, and before sedation (if any); 6. The legal representative signed the informed consent; 7. advanced life support is conducted.

Exclusion criteria

Exclusion criteria: 1. No-flow time >10 min (time from collapse to initiation of external cardiac massage); 2. Low-flow time >60 min (time from initiation of external cardiac massage to ROSC); 3. Major hemodynamic instability (defined as a continuous epinephrine or norepinephrine infusion at a flow rate >1 µg/Kg/min); 4. Cardiac arrest caused by advanced tumor and other end-of-state diseases; 5. Cardiac arrest caused by an irreversible cause (such as Severe trauma and poisoning); 6. Cardiogenic cardiac arrest (acute infarction, malignant arrhythmia, heart failure, etc.); 7. Acupoint with lesions, wounds, or skin diseases affects acupuncture; 8. Allergic persons, or known to be allergic to treatment, such as metal; 9. pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
survival with a favorable neurological outcome;

Countries

China

Contacts

Public ContactZeng Ruifeng

Guangdong Provincial Hospital of Chinese Medicine

raynorz@gzucm.edu.cn+86 13760872664

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026